Cargando…
Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease?
Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable coronary artery disease (sCAD) and total occlusion in at least one vessel (n = 249). We divided th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573799/ https://www.ncbi.nlm.nih.gov/pubmed/37835005 http://dx.doi.org/10.3390/jcm12196361 |
_version_ | 1785120544924893184 |
---|---|
author | Doğan, Yasemin Yilmaz, Yücel Kelesoğlu, Saban Calapkorur, Bekir Neşelioglu, Salim Erel, Özcan Kalay, Nihat |
author_facet | Doğan, Yasemin Yilmaz, Yücel Kelesoğlu, Saban Calapkorur, Bekir Neşelioglu, Salim Erel, Özcan Kalay, Nihat |
author_sort | Doğan, Yasemin |
collection | PubMed |
description | Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable coronary artery disease (sCAD) and total occlusion in at least one vessel (n = 249). We divided the patients into two groups, good and poor, according to their CCC degree. We determined that DM, total thiol, and disulfide are independent predictors of poor CCC in multivariate logistic regression analysis (OR: 1.012, 95% CI: 1.008–1.017, p < 0.001; OR: 1.022, 95% CI: 1.000–1.044, p = 0.044; OR: 2.671, 95% CI: 1.238–5.761, p = 0.012, respectively). The ROC analysis showed a cut-off value of 328.7 for native thiol regarding the prediction of poor CCC, with 67.4% specificity and 78% sensitivity. For disulfide, it revealed a cut-off value of 15.1 regarding the prediction of poor CCC, with 57.9% specificity and 69.5% sensitivity. In this study, we detected that the patients with sCAD who developed poor CCC had lower levels of native thiol, total thiol, and disulfide compared to those with good CCC. The most interesting finding of our study is that CCC formation is an effective predictor of the antioxidant cascade rather than the inflammation cascade in sCAD patients. |
format | Online Article Text |
id | pubmed-10573799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105737992023-10-14 Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? Doğan, Yasemin Yilmaz, Yücel Kelesoğlu, Saban Calapkorur, Bekir Neşelioglu, Salim Erel, Özcan Kalay, Nihat J Clin Med Article Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable coronary artery disease (sCAD) and total occlusion in at least one vessel (n = 249). We divided the patients into two groups, good and poor, according to their CCC degree. We determined that DM, total thiol, and disulfide are independent predictors of poor CCC in multivariate logistic regression analysis (OR: 1.012, 95% CI: 1.008–1.017, p < 0.001; OR: 1.022, 95% CI: 1.000–1.044, p = 0.044; OR: 2.671, 95% CI: 1.238–5.761, p = 0.012, respectively). The ROC analysis showed a cut-off value of 328.7 for native thiol regarding the prediction of poor CCC, with 67.4% specificity and 78% sensitivity. For disulfide, it revealed a cut-off value of 15.1 regarding the prediction of poor CCC, with 57.9% specificity and 69.5% sensitivity. In this study, we detected that the patients with sCAD who developed poor CCC had lower levels of native thiol, total thiol, and disulfide compared to those with good CCC. The most interesting finding of our study is that CCC formation is an effective predictor of the antioxidant cascade rather than the inflammation cascade in sCAD patients. MDPI 2023-10-04 /pmc/articles/PMC10573799/ /pubmed/37835005 http://dx.doi.org/10.3390/jcm12196361 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Doğan, Yasemin Yilmaz, Yücel Kelesoğlu, Saban Calapkorur, Bekir Neşelioglu, Salim Erel, Özcan Kalay, Nihat Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title | Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title_full | Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title_fullStr | Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title_full_unstemmed | Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title_short | Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease? |
title_sort | are thiols useful biomarkers for coronary collateral circulation in patients with stable coronary artery disease? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573799/ https://www.ncbi.nlm.nih.gov/pubmed/37835005 http://dx.doi.org/10.3390/jcm12196361 |
work_keys_str_mv | AT doganyasemin arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT yilmazyucel arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT kelesoglusaban arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT calapkorurbekir arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT neselioglusalim arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT erelozcan arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease AT kalaynihat arethiolsusefulbiomarkersforcoronarycollateralcirculationinpatientswithstablecoronaryarterydisease |